| scholarly article | Q13442814 |
| P50 | author | Christine E. Seidman | Q30123970 |
| P2093 | author name string | Libin Wang | |
| Charles I. Berul | |||
| Michael Arad | |||
| Tetsuo Konno | |||
| Ronny Alcalai | |||
| David Planer | |||
| Hiroko Wakimoto | |||
| Jon G. Seidman | |||
| P2860 | cites work | Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak | Q24296910 |
| Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia | Q24299780 | ||
| Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes | Q24315860 | ||
| Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans | Q24608179 | ||
| Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death | Q24674590 | ||
| Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia | Q28142708 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel | Q28204838 | ||
| Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia | Q28235110 | ||
| Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin | Q28237997 | ||
| Quantitation of protein | Q28279026 | ||
| Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia | Q28279395 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia | Q28589230 | ||
| Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. | Q33146452 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. | Q33152686 | ||
| Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia | Q33155477 | ||
| Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia | Q33157356 | ||
| Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients | Q33173888 | ||
| Cardiac electrophysiology in genetically engineered mice | Q33882437 | ||
| Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum | Q34126333 | ||
| Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. | Q34661902 | ||
| Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death. | Q36791253 | ||
| Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias | Q37339393 | ||
| Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor | Q37355318 | ||
| ATPase Activities, Ca2+ Transport and Phosphoprotein Formation in Sarcoplasmic Reticulum Subfractions of Fast and Slow Rabbit Muscles | Q39840965 | ||
| Sarcoplasmic reticulum calsequestrins: structural and functional properties | Q40565740 | ||
| Modified release verapamil induced cardiogenic shock | Q41990514 | ||
| Calsequestrin: more than 'only' a luminal Ca2+ buffer inside the sarcoplasmic reticulum | Q42992388 | ||
| Intra-sarcoplasmic reticulum Ca2+ oscillations are driven by dynamic regulation of ryanodine receptor function by luminal Ca2+ in cardiomyocytes | Q43286787 | ||
| Quantitative assessment of the SR Ca2+ leak-load relationship | Q44167973 | ||
| Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations | Q45273441 | ||
| Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes. | Q54135977 | ||
| Hormonal control of Mg2+ transport in the heart | Q59095759 | ||
| In vivo cardiac electrophysiology studies in the mouse | Q71785180 | ||
| Impaired cell shortening and relengthening with increased pacing frequency are intrinsic to the senescent mouse cardiomyocyte | Q73098110 | ||
| Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms | Q73207956 | ||
| Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia | Q78390804 | ||
| Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model | Q79851890 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ventricular tachycardia | Q56002 |
| heart arrhythmia | Q189331 | ||
| tachycardia | Q209583 | ||
| catecholaminergic polymorphic ventricular tachycardia | Q1649897 | ||
| P304 | page(s) | 316-324 | |
| P577 | publication date | 2010-08-30 | |
| P1433 | published in | Journal of Cardiovascular Electrophysiology | Q4736917 |
| P1476 | title | Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation | |
| Prevention of Ventricular Arrhythmia and Calcium Dysregulation in a Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model Carrying Calsequestrin-2 Mutation | |||
| P478 | volume | 22 |
| Q51864131 | A key role of TRPC channels in the regulation of electromechanical activity of the developing heart. |
| Q30416051 | Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes |
| Q36941532 | Calsequestrin 2 deletion shortens the refractoriness of Ca²⁺ release and reduces rate-dependent Ca²⁺-alternans in intact mouse hearts |
| Q38125941 | Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects |
| Q28589538 | Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor |
| Q38602828 | Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin. |
| Q36559205 | L-Type Calcium Channels Do Not Play a Critical Role in Chest Blow Induced Ventricular Fibrillation: Commotio Cordis |
| Q89961129 | Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia |
| Q38494265 | Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application. |
| Q33160416 | Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.